Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38 INR | +4.48% | +9.42% | -28.26% |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 254.6 | 124.7 | 77.19 | 73.53 | 87.12 | 141.2 |
Enterprise Value (EV) 1 | 469.6 | 338.4 | 303.9 | 278 | 315.8 | 336.4 |
P/E ratio | 27.7 x | 17.2 x | 17.3 x | 14.9 x | 38.2 x | 63.5 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.43 x | 0.21 x | 0.17 x | 0.17 x | 0.38 x | 0.53 x |
EV / Revenue | 0.79 x | 0.57 x | 0.69 x | 0.62 x | 1.37 x | 1.26 x |
EV / EBITDA | 15.3 x | 8.36 x | 7.44 x | 10.5 x | 16.5 x | 12.1 x |
EV / FCF | -19 x | 157 x | -28.5 x | 23.7 x | -10.3 x | 10.8 x |
FCF Yield | -5.27% | 0.64% | -3.51% | 4.23% | -9.72% | 9.28% |
Price to Book | 2.89 x | 1.32 x | 0.78 x | 0.72 x | 0.83 x | 1.33 x |
Nbr of stocks (in thousands) | 4,300 | 4,300 | 4,300 | 4,300 | 4,302 | 4,302 |
Reference price 2 | 59.20 | 29.00 | 17.95 | 17.10 | 20.25 | 32.82 |
Announcement Date | 9/6/18 | 9/3/19 | 12/2/20 | 9/2/21 | 9/3/22 | 7/13/23 |
Income Statement Evolution (Annual data)
Fiscal Period: März | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 598 | 591.1 | 442.2 | 444.9 | 231.2 | 267.6 |
EBITDA 1 | 30.73 | 40.46 | 40.84 | 26.59 | 19.14 | 27.79 |
EBIT 1 | 27.14 | 36.42 | 36.75 | 22.33 | 15.05 | 23.84 |
Operating Margin | 4.54% | 6.16% | 8.31% | 5.02% | 6.51% | 8.91% |
Earnings before Tax (EBT) 1 | 12.08 | 9.041 | 4.226 | 4.665 | 1.973 | 2.643 |
Net income 1 | 9.182 | 7.266 | 4.457 | 4.931 | 2.299 | 2.224 |
Net margin | 1.54% | 1.23% | 1.01% | 1.11% | 0.99% | 0.83% |
EPS 2 | 2.135 | 1.690 | 1.037 | 1.147 | 0.5300 | 0.5172 |
Free Cash Flow 1 | -24.73 | 2.151 | -10.66 | 11.75 | -30.71 | 31.23 |
FCF margin | -4.14% | 0.36% | -2.41% | 2.64% | -13.28% | 11.67% |
FCF Conversion (EBITDA) | - | 5.32% | - | 44.18% | - | 112.38% |
FCF Conversion (Net income) | - | 29.61% | - | 238.27% | - | 1,404.29% |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 9/6/18 | 9/3/19 | 12/2/20 | 9/2/21 | 9/3/22 | 7/13/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 215 | 214 | 227 | 205 | 229 | 195 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 6.997 x | 5.281 x | 5.551 x | 7.69 x | 11.95 x | 7.026 x |
Free Cash Flow 1 | -24.7 | 2.15 | -10.7 | 11.7 | -30.7 | 31.2 |
ROE (net income / shareholders' equity) | 10.7% | 7.97% | 4.63% | 4.92% | 2.23% | 2.11% |
ROA (Net income/ Total Assets) | 3.4% | 3.48% | 3.27% | 2.48% | 2.26% | 3.8% |
Assets 1 | 269.8 | 208.5 | 136.4 | 199.1 | 101.6 | 58.57 |
Book Value Per Share 2 | 20.50 | 21.90 | 22.90 | 23.70 | 24.30 | 24.70 |
Cash Flow per Share 2 | 0.0800 | 0.1300 | 0.1100 | 0.1400 | 0.3200 | 0.1500 |
Capex 1 | 13 | 8.69 | 4.57 | 1.87 | 1.07 | 0.09 |
Capex / Sales | 2.18% | 1.47% | 1.03% | 0.42% | 0.46% | 0.03% |
Announcement Date | 9/6/18 | 9/3/19 | 12/2/20 | 9/2/21 | 9/3/22 | 7/13/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-28.26% | 1.87M | |
+19.30% | 39.76B | |
-.--% | 11.16B | |
-1.90% | 7.56B | |
+2.38% | 6.62B | |
-5.50% | 5.94B | |
-4.27% | 5.74B | |
-11.80% | 5.54B | |
+29.81% | 5.13B | |
+10.65% | 3.89B |
- Stock Market
- Equities
- PHYTO6 Stock
- Financials Phyto Chem (India) Limited